Tdspharm (464280.KQ) Earnings Analysis
Tdspharm (464280.KQ) has no confirmed upcoming earnings date. Trailing P/E 5.72.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 464280.KQ next report earnings?
No confirmed upcoming earnings date is currently scheduled for 464280.KQ. This page updates as the calendar is published.
464280.KQ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-10 | 300.21 KRW | n/a | n/a | n/a |
| 2025-11-14 | 276 KRW | n/a | n/a | n/a |
| 2025-08-14 | 162 KRW | n/a | n/a | n/a |
| 2024-12-31 | 112.65 KRW | n/a | n/a | n/a |
| 2024-09-30 | 199 KRW | n/a | n/a | n/a |
464280.KQ valuation and analyst view
| Trailing P/E | 5.72 |
|---|---|
| Trailing EPS | 955.76 KRW |
| Price / book | 0.66 |
| Dividend yield | 0.00% |
| Market cap | 29.03B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Tdspharm (464280.KQ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 464280.KQ. This page updates as the calendar is published.
Did 464280.KQ beat earnings last quarter?
Consensus estimate data was not available for 464280.KQ's 2026-03-10 report.
What is 464280.KQ's current P/E ratio and EPS?
464280.KQ trades at a trailing P/E of 5.72 on trailing EPS of 955.7605288834263 KRW.
What do analysts rate 464280.KQ?
464280.KQ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.